arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Wellgistics Health, Inc.

WGRX

$3.50 0.00 (0.00%) at close

11 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

Wellgistics Health, Inc. faces fundamental challenges. On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $366.2M

Dividend Yield —

Revenue Growth -85.6% →

Op. Margin -385.7%

ROIC -37.4% ↗

FCF / Share $-0.03

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -1.84

info Valuation on last close. End-of-day price, Jul 21, 2026.

11-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.56M

↓ -85.6% —

Net Income Profit after all expenses

$-7.74M

↑ +76.1% —

Operating Margin Operating profit as % of sales

-385.7%

↓ -446.3% 0th

FCF / Share Free cash flow per share

$-0.03

↓ -25.7% —

Long-Term Debt Long-term obligations

$27.77M

↑ +18.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	-85.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1171%)	-86.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1182%)	-46.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-686%)	17391.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+217298%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	88.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-150.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1050.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-1000.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	76.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-543.0% Weak ↑ Weak Improving Year-over-year change in net income	-38916.0% Weak → Weak Stable Year-over-year change in net income	-38916.0% Weak Weak Year-over-year change in net income	-38916.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-25.7% Weak Weak Year-over-year change in free cash flow	—	N/M	N/M	N/M	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-385.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2671%)	—	—	-70.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-571%)	-288.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2024%)	-30.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-301%)	-30.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-305%)	—	—	—	—
Profit Margin (%) (%)	-496.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4237%)	—	—	-416.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3569%)	-298.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2588%)	-34.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-391%)	-1.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-112%)	-186.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1655%)	—	—	—
FCF Margin (%) (%)	-218.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-376.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-37.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-26.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-12.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-21.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	18.3% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.44x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-12.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-3.97x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-37.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-181.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-78.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-86.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	2.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-20.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	51.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+243%)	223.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1392%)	—	—	—	-64.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-529%)	-0.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-106%)	2.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	2.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-81%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	-1.84x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-407%)	-1.89x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-414%)	3.66x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+510%)	25.72x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+4186%)	5.39x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+798%)	3.47x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+479%)	—	—	—	—	—
Interest Coverage (x)	-45.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-49.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-50.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$27.72M	$23.44M	$20.58M	$22.86M	$21.61M	$22.35M	—	—	—	$-1.36K	—
Debt / EBITDA (x)	-4.64x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.79x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.26x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.77x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.31x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$0.01	—	$0.04	$0.13	$0.21	—	$0.12	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-0.07	$-0.25	$-0.46	$-0.11	$-0.62	$-0.10	$-0.04	$-0.01	$0.00	—	—
Free Cash Flow per Share (USD)	$-0.03	—	$-0.02	$-0.03	$-0.03	—	$0.02	$0.01	$0.00	—	—
Book Value per Share (USD)	$-0.13	$-0.12	$0.08	$0.01	$0.07	$0.13	$0.21	$-0.07	$-0.07	$-0.06	—
Tangible Book Value per Share (USD)	$-0.27	$-0.29	$-0.13	$-0.27	$-0.22	$-0.22	$0.21	$-0.07	$-0.07	$-0.06	—
Basic Weighted Avg Shares (shares)	104.62M	—	74.38M	61.77M	51.92M	—	48.40M	45.90M	44.72M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$-29.44M	$-26.96M	$-19.92M	$-28.89M	$-29.67M	$-22.88M	—	—	—	$-2.55M	—
LT Debt (USD)	$27.77M	$23.49M	$24.81M	$23.28M	$24.12M	$23.38M	—	—	—	—	—
Total Equity (USD)	$-15.06M	$-12.45M	$6.78M	$905.25K	$4.48M	$6.73M	$9.99M	$-3.15M	$-2.98M	$-2.90M	$-5.25K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$1.56M	$1.67M	$3.01M	$7.79M	$10.86M	$12.41M	$5.67M	$44.54K	—	—	—
Depreciation Expense (USD)	$27.86K	$39.53K	$39.73K	$39.73K	$39.81K	$40.44K	$27.17K	$0.00	—	—	—
Net Income, GAAP (USD)	$-7.74M	$-27.85M	$-32.43M	$-32.43M	$-32.43M	$-4.33M	$-83.12K	$-83.12K	$-83.12K	—	—
Operating Cash Flow (USD)	$-3.41M	$-6.29M	$-1.14M	$-2.08M	$-1.35M	$-2.62M	$1.04M	$329.96K	$31.24K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters

Wellgistics Health, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare WGRX with peers